Dipeptide γ-secretase inhibitor treatment enhances the anti-tumor effects of cisplatin against gastric cancer by suppressing cancer stem cell properties.
暂无分享,去创建一个
H. Shiraha | S. Horiguchi | M. Iwamuro | Ken Matsumoto | H. Okada | D. Uchida | K. Tsutsumi | A. Ohyama | T. Nagahara | Ryo Kato | H. Sawahara | Emi Tanaka
[1] L. Qin,et al. Upregulated miR‐132 in Lgr5+ gastric cancer stem cell‐like cells contributes to cisplatin‐resistance via SIRT1/CREB/ABCG2 signaling pathway , 2017, Molecular carcinogenesis.
[2] Tetsuji Yamaguchi,et al. Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer , 2016, Oncology letters.
[3] X. Yang,et al. Gastric Lgr5+ stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice , 2016, Cell Research.
[4] Yong-zhong Wu,et al. Gastric tumor-initiating CD44+ cells and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT. , 2015, Oncology letters.
[5] Chao Liu,et al. Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer , 2015, Cellular Physiology and Biochemistry.
[6] E. Keller,et al. Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer , 2015, Clinical Cancer Research.
[7] I. Choi,et al. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer , 2015, Clinical & Experimental Metastasis.
[8] Guiyu Wang,et al. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor , 2015, Molecular medicine reports.
[9] M. Cristofanilli,et al. Cancer stem cells: implications for cancer therapy. , 2014, Oncology.
[10] A. Capobianco,et al. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. , 2014, Cancer research.
[11] J. Medema,et al. Cancer stem cells – important players in tumor therapy resistance , 2014, The FEBS journal.
[12] Zongguang Zhou,et al. Role of Notch signaling pathway in gastric cancer: a meta-analysis of the literature. , 2014, World journal of gastroenterology.
[13] Edward J. Kim,et al. The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer , 2014, PloS one.
[14] Guihua Xu,et al. Cancer stem cells: the ‘heartbeat’ of gastric cancer , 2013, Journal of Gastroenterology.
[15] H. Xi,et al. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer. , 2013, Oncology reports.
[16] K. Gajiwala,et al. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. , 2013, Cancer letters.
[17] Edward Kai-Hua Chow,et al. Mechanisms of chemoresistance in cancer stem cells , 2013, Clinical and Translational Medicine.
[18] S. Vinogradov,et al. Cancer stem cells and drug resistance: the potential of nanomedicine. , 2012, Nanomedicine.
[19] Y. Liang,et al. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype , 2012, Oncogene.
[20] Kun Yang,et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients , 2011, Cell Research.
[21] Sik Yoon,et al. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research , 2011, Cellular and Molecular Life Sciences.
[22] H. Juan,et al. Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma , 2010, Clinical Cancer Research.
[23] Lun Zhang,et al. Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. , 2010, Oncology reports.
[24] Lun Zhang,et al. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.
[25] M. Katoh,et al. Dysregulation of stem cell signaling network due to germline mutation, SNP, helicobacter pylori infection, epigenetic change, and genetic alteration in gastric cancer , 2007, Cancer biology & therapy.
[26] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[27] Lun Zhang,et al. Correlation of Notch 1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma , 2022 .